Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 276 followers

Latest posts

Last updated about 17 hours ago

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 10, Status: Authorised

about 18 hours ago

Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of...

Careers

about 19 hours ago

Careers

Who we are

about 19 hours ago

Who we are

EMA Gender equality plan 2025 - 2030

about 20 hours ago

EMA Gender equality plan 2025 - 2030

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Status: Authorised

about 20 hours ago

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of...

Opinions and letters of support on the qualification of novel methodologies for medicine development

about 20 hours ago

Opinions and letters of support on the qualification of novel methodologies for...

Draft qualification opinion for Simcyp Simulator

about 21 hours ago

Draft qualification opinion for Simcyp Simulator

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation: 15/02/2006, Revision: 36, Status: Authorised

about 21 hours ago

Human medicines European public assessment report (EPAR): Neupro, rotigotine, Date of authorisation...

Supporting innovation

about 21 hours ago

Supporting innovation

European Medicines Agency Write PMS API implementation Guide (zip)

about 21 hours ago

European Medicines Agency Write PMS API implementation Guide (zip)

Process for the electronic submission of medicinal product information - Chapter 3

about 21 hours ago

Process for the electronic submission of medicinal product information - Chapter 3

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 May 2025

about 22 hours ago

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 May 2025